BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 15773962)

  • 1. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
    Bemelman F; Yong SL; Tissingh R; Schellekens P; ten Berge I
    Transpl Int; 2005 Apr; 18(4):423-8. PubMed ID: 15773962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell suppression in transplantation tolerance through linked recognition.
    Davies JD; Leong LY; Mellor A; Cobbold SP; Waldmann H
    J Immunol; 1996 May; 156(10):3602-7. PubMed ID: 8621893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split tolerance in spleen chimeras.
    Sprent J; Hurd M; Schaefer M; Heath W
    J Immunol; 1995 Feb; 154(3):1198-206. PubMed ID: 7822792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection.
    Oukka M; Galou M; Belkaid Y; Tricotet V; Riche N; Reynes M; Kosmatopoulos K
    Eur J Immunol; 1997 Dec; 27(12):3499-506. PubMed ID: 9464840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice.
    Rodríguez-Barbosa JI; Haller GW; Zhao G; Sachs DH; Sykes M
    Transpl Immunol; 2005 Oct; 15(1):25-33. PubMed ID: 16223670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor antigen-presenting cells are important in the development of obliterative airway disease.
    Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
    Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
    Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
    Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
    Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
    Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction.
    Mayumi H; Good RA
    Immunobiology; 1989 Mar; 179(1):86-108. PubMed ID: 2659501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice.
    Hasková Z; Filipec M; Holán V
    Folia Biol (Praha); 1996; 42(3):105-11. PubMed ID: 8971221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
    Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
    J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linked suppression of skin graft rejection can operate through indirect recognition.
    Wise MP; Bemelman F; Cobbold SP; Waldmann H
    J Immunol; 1998 Dec; 161(11):5813-6. PubMed ID: 9834057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a novel method to induce tolerance in adult mice across fully allogeneic (entire H-2 plus multiminor histocompatibility) antigen barriers, using supralethal irradiation followed by injection of syngeneic bone marrow cells plus (donor X recipient) F1 spleen cells.
    Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
    Immunobiology; 1989 Jun; 179(2-3):214-29. PubMed ID: 2793203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.